| Head and Neck Cancer |
1 |
1 |
| Biologic Therapy |
0 |
1 |
| Otolaryngology |
0 |
0.7 |
| Immunotherapy |
0 |
0.54 |
| Neoadjuvant Therapy |
0 |
0.47 |
| Cancer |
0 |
0.37 |
| Cervical Region |
0 |
0.37 |
| Squamous Cell Carcinoma |
0 |
0.34 |
| Chemotherapy |
0 |
0.27 |
| Head and Neck Surgery |
0 |
0.27 |
| Clinical Research |
0 |
0.24 |
| Radiation Therapy |
0 |
0.2 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.19 |
| HIV Infection |
0 |
0.19 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.17 |
| Tumor |
0 |
0.14 |
| Meta-Analysis |
0 |
0.1 |
| Surgery |
0 |
0.07 |
| Tobacco Cessation |
0 |
0.07 |
| Tobacco Use |
0 |
0.06 |
| Inflammatory Bowel Disease |
0 |
0.04 |
| Antigens |
0 |
0.03 |
| Colitis |
0 |
0.03 |
| Duodenum |
0 |
0.03 |
| Hemorrhage |
0 |
0.03 |
| Lymph Node |
0 |
0.03 |
| Mucositis |
0 |
0.03 |
| Nausea |
0 |
0.03 |
| Platinum |
0 |
0.03 |
| Refractory |
0 |
0.03 |
| Single-Agent Therapy |
0 |
0.03 |
| Syncope |
0 |
0.03 |
| Tolerance |
0 |
0.03 |